WilmerHale Advises Cue Health in IPO

WilmerHale Advises Cue Health in IPO

Client News

Related Solutions

Leveraging our sophisticated technical, market and legal experience to help clients effectively and efficiently manage complex transactions and get the deal done.
Helping clients launch their businesses and transform their innovative ideas into successful companies.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
A deep and diverse practice focused on maximizing tax efficiencies and minimizing tax risks for clients nationally and internationally.
Critical industry insight and formidable strength across key practices.

On September 23, 2021, Cue Health (Nasdaq: HLTH), a health technology company, announced the pricing of its initial public offering of 12,500,000 shares of its common stock at a public offering price of $16.00 per share, for gross proceeds of $200.00 million, before deducting underwriting discounts and commissions and other offering expenses payable by Cue Health. 

Cue Health’s common stock began trading on the Nasdaq Global Select Market on September 24, 2021 and the offering is expected to close on September 28, 2021, subject to the satisfaction of customary closing conditions. In addition, Cue Health has granted the underwriters a 30-day option to purchase up to 1,875,000 additional shares of common stock at the initial public offering price, less the underwriting discounts and commissions.

The WilmerHale team advising Cue Health is led by Todd Rumberger and Glenn Pollner and includes Molly Fox, Craig Hilts, Dimitry Lensky, Andrea Sorrentino, Jahnvi Desai, Amanda Navarro and Benn Waters, with assistance from Fred Adam, Ciara Baker, Kimberly Wethly, Rebecca Chang, Benjamin Kelsey, Gavin Tullis and Heidi Treiber. 

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel